Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur

International Journal of Clinical Oncology

Volumn 9, Issue 2, 2004, Pages 98-106

  Watanabe, Masahiko ^a,b   Nishida, Osamu ^b   Kunii, Yasuo ^b   Kodaira, Susumu ^b   Takahashi, Takashi ^b   Tominaga, Takeshi ^b   Hojyo, Keiichi ^b   Kato, Tomoyuki ^b   Niimoto, Minoru ^b   Kunitomo, Kazufumi ^b   Isomoto, Hiroyasu ^b   Ohashi, Yasuo ^b   Yasutomi, Masayuki ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b The Japan Foundation   (Japan)

Author keywords

Adjuvant immunochemotherapy; Colorectal cancer; HCFU; OK 432; UFT

Indexed keywords

CARMOFUR; FLUOROURACIL; MITOMYCIN C; PICIBANIL; TEGAFUR;

ADULT; AGED; ALOPECIA; ANOREXIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEELING HOT; FEMALE; FEVER; HEMATURIA; HEMOGLOBINEMIA; HEMOGLOBINOPATHY; HUMAN; HYPERPYREXIA; HYPOTENSION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RESPIRATORY TRACT DISEASE; SENSORY DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; URINARY FREQUENCY; VOMITING;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DRUG COMBINATIONS; FEMALE; FLUOROURACIL; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; PICIBANIL; PYRIMIDINES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 2442508956     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-003-0374-0     Document Type: Article

References (16)

1. Macdonald JS, Astrow AB (2001) Adjuvant therapy of colon cancer. Semin Oncol 28:30-40
2. Wils J, O'Dwyer P, Labianca R (2001) Adjuvant treatment of colorectal cancer at the turn of the century: European and US perspectives. Ann Oncol 12:13-22
3. Ragnhammar P, Hafstrom L, Nygren P (2001) A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 40:282-308
4. Yasutomi M, Takahashi T, Kodaira S, et al. (1997) Prospective controlled study on the usefulness of carmofur as a postoperative adjuvant chemotherapy for colorectal cancer. Gan To Kagaku Ryoho 24:1953-1960
5. Kodaira S, Kikuchi K, Yasutomi M, et al. (1998) Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results from the Cooperative Project No. 7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer. Int J Clin Oncol 3:357-364
6. Sugimachi K, Maehara Y, Ogawa M, et al. (1996) Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection. Cancer 77:36-43
7. Ito K, Yamaguchi A, Miura K, et al. (1996) Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer. J Surg Oncol 62:4-9
8. Kato T, Ohashi Y, Nakazato H, et al. (2002) Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial. Langenbeck's Arch Chir 386:575-581
9. Windle R, Bell PR, Shaw D (1987) Five-year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Br J Surg 74:569-572
10. Japanese Research Society for Cancer of Colon and Rectum (1985) General rules for clinical and pathological studies on cancer of colon, rectum and anus, 4th edn. Kanehara Shuppan, Tokyo
11. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colorectal cancer. Lancet 345:939-944
12. Zaniboni A (1997) Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival. J Clin Oncol 15:2432-2441
13. Wolmark N, Rockette H, Mamounas E, et al. (1999) Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol 17:3553-3559
14. Smith RE, Lembersky BC (2000) UFT/leucovorin vs 5-FU/leucovorin in colon cancer. Oncology(Huntingt) 14:24-27
15. Douillard J, Cunningham D, Roth A, et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomized trial. Lancet 355:1041-1047
16. Levi F, Zidani R, Misset JL (1997) Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chemotherapy. Lancet 350:681-686